エクソソーム (小胞)とは? わかりやすく解説

Weblio 辞書 > 辞書・百科事典 > 百科事典 > エクソソーム (小胞)の意味・解説 

エクソソーム (小胞)

出典: フリー百科事典『ウィキペディア(Wikipedia)』 (2024/02/16 18:29 UTC 版)

エクソソームまたはエキソソーム: exosome)は、大部分の真核細胞において、エンドソーム区画で形成される膜結合性の細胞外小胞英語版(extracellular vesicle、EV)である[1][2][3]


  1. ^ a b c Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, etal (2018). “Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines”. Journal of Extracellular Vesicles 7 (1): 1535750. doi:10.1080/20013078.2018.1535750. PMC 6322352. PMID 30637094. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322352/. 
  2. ^ Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, Buzas K, etal (2015). “Biological properties of extracellular vesicles and their physiological functions”. Journal of Extracellular Vesicles 4: 27066. doi:10.3402/jev.v4.27066. PMC 4433489. PMID 25979354. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433489/. 
  3. ^ van Niel G, D'Angelo G, Raposo G (April 2018). “Shedding light on the cell biology of extracellular vesicles”. Nature Reviews. Molecular Cell Biology 19 (4): 213-228. doi:10.1038/nrm.2017.125. PMID 29339798. 
  4. ^ a b c d van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R (July 2012). “Classification, functions, and clinical relevance of extracellular vesicles”. Pharmacological Reviews 64 (3): 676-705. doi:10.1124/pr.112.005983. PMID 22722893. https://semanticscholar.org/paper/95db79458a12e1c8c20bdd385bcbdd0a287d78f0. 
  5. ^ Keller S, Sanderson MP, Stoeck A, Altevogt P (November 2006). “Exosomes: from biogenesis and secretion to biological function”. Immunology Letters 107 (2): 102-8. doi:10.1016/j.imlet.2006.09.005. PMID 17067686. 
  6. ^ Spaull R, McPherson B, Gialeli A, Clayton A, Uney J, Heep A, Cordero-Llana Ó (April 2019). “Exosomes populate the cerebrospinal fluid of preterm infants with post-haemorrhagic hydrocephalus”. International Journal of Developmental Neuroscience 73: 59-65. doi:10.1016/j.ijdevneu.2019.01.004. PMID 30639393. 
  7. ^ a b Dhondt B, Van Deun J, Vermaerke S, de Marco A, Lumen N, De Wever O, Hendrix A (June 2018). “Urinary extracellular vesicle biomarkers in urological cancers: From discovery towards clinical implementation”. The International Journal of Biochemistry & Cell Biology 99: 236-256. doi:10.1016/j.biocel.2018.04.009. PMID 29654900. 
  8. ^ エクソソーム等の調製・治療に対する考え⽅ 日本再生医療学会(2021年3月10日)2023年11月26日閲覧
  9. ^ エクソソーム美容診療の規制を 再生医療学会が提言東京新聞TOKYO Web 2023年11月10日 掲載の共同通信記事(2023年11月26日閲覧)
  10. ^ a b c Public Safety Notification on Exosome Products”. FDA (2019年12月6日). 2023年2月27日閲覧。
  11. ^ a b Kimera Labs FDA letter cites exosomes for COVID-19, more issues”. The Niche (2020年4月23日). 2023年2月27日閲覧。
  12. ^ 未承認exosomes製品による治療のため、複数の患者に深刻な有害事象が発生している”. メディカルオンライン (2019年12月9日). 2023年2月27日閲覧。
  13. ^ a b Limited Reporting of Adverse Events Tied to Regenerative Treatments Leaves Consumers Vulnerable”. Pew (2020年7月31日). 2023年2月27日閲覧。
  14. ^ Warning Letters Week of 4/20/2020: Untitled Letter to Stem Cell Firm”. redica (2020年4月27日). 2023年2月27日閲覧。
  15. ^ コロナ後遺症に日本初の専門クリニック 幹細胞培養液エクソソーム投与 投与は5種類 「本田クリニック」本田昌毅総院長に聞く”. 夕刊フジ (2023年2月23日). 2023年2月27日閲覧。
  16. ^ コロナ・ワクチン後遺症専門 本田クリニック”. 2023年2月27日閲覧。
  17. ^ 幹細胞治療で内側から若返る。”. Madame Figaro (2023年2月24日). 2023年2月27日閲覧。
  18. ^ 再生医療による美容治療を提供する銀座美容メディカルクリニックが、2月よりアンチエイジングの効果が期待できる“エクソソーム療法”の従来の点滴に加えて点鼻療法の提供も併せて開始することをお知らせいたします”. dreamnews (2023年2月6日). 2023年2月27日閲覧。
  19. ^ 《新発売》最先端研究の結晶<ヒトサイタイ血由来幹細胞エクソソーム+ヒト臍帯血細胞順化培養液>新規化粧品原料 「FCJ-EX1」発売開始!~赤ちゃん由来の幹細胞エクソソームで美を追求する~”. prtimes (2022年8月30日). 2023年2月27日閲覧。
  20. ^ 『カズレーザーと学ぶ。』今回のテーマは『遺伝と才能』『エクソソーム』『日本人の体の変化』”. 日本テレビ (2023年1月10日). 2023年2月27日閲覧。
  21. ^ Harding, Clifford; Stahl, Philip (1983-06-15). “Transferrin recycling in reticulocytes: pH and iron are important determinants of ligand binding and processing”. Biochemical and Biophysical Research Communications 113 (2): 650-658. doi:10.1016/0006-291X(83)91776-X. ISSN 0006-291X. PMID 6870878. 
  22. ^ Pan, Bin-Tao; Johnstone, Rose M. (July 1983). “Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor”. Cell 33 (3): 967-978. doi:10.1016/0092-8674(83)90040-5. PMID 6307529. 
  23. ^ Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C (July 1987). “Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)”. The Journal of Biological Chemistry 262 (19): 9412-20. PMID 3597417. 
  24. ^ van Niel G, Porto-Carreiro I, Simoes S, Raposo G (July 2006). “Exosomes: a common pathway for a specialized function”. Journal of Biochemistry 140 (1): 13-21. doi:10.1093/jb/mvj128. PMID 16877764. https://semanticscholar.org/paper/5f7bf5ebe0366eb726acba754208ce771fc87e62. 
  25. ^ Huotari J, Helenius A (August 2011). “Endosome maturation”. The EMBO Journal 30 (17): 3481-500. doi:10.1038/emboj.2011.286. PMC 3181477. PMID 21878991. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181477/. 
  26. ^ Gruenberg J, van der Goot FG (July 2006). “Mechanisms of pathogen entry through the endosomal compartments”. Nature Reviews. Molecular Cell Biology 7 (7): 495-504. doi:10.1038/nrm1959. PMID 16773132. 
  27. ^ Maguire, Greg (2016) (英語). Fabrication and Self-Assembly of Nanobiomaterials. Elsevier. pp. 179-209. doi:10.1016/b978-0-323-41533-0.00007-6. ISBN 978-0-323-41533-0. https://linkinghub.elsevier.com/retrieve/pii/B9780323415330000076 
  28. ^ a b c Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (June 2007). “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells”. Nature Cell Biology 9 (6): 654-9. doi:10.1038/ncb1596. PMID 17486113. 
  29. ^ Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, Zheng Y, Hoshino A, Brazier H, Xiang J, Williams C, Rodriguez-Barrueco R, Silva JM, Zhang W, Hearn S, Elemento O, Paknejad N, Manova-Todorova K, Welte K, Bromberg J, Peinado H, Lyden D (June 2014). “Double-stranded DNA in exosomes: a novel biomarker in cancer detection”. Cell Research 24 (6): 766-9. doi:10.1038/cr.2014.44. PMC 4042169. PMID 24710597. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042169/. 
  30. ^ a b Li XB, Zhang ZR, Schluesener HJ, Xu SQ (2006). “Role of exosomes in immune regulation”. Journal of Cellular and Molecular Medicine 10 (2): 364-75. doi:10.1111/j.1582-4934.2006.tb00405.x. PMC 3933127. PMID 16796805. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933127/. 
  31. ^ Hough KP, Chanda D, Duncan SR, Thannickal VJ, Deshane JS (April 2017). “Exosomes in immunoregulation of chronic lung diseases”. Allergy 72 (4): 534-544. doi:10.1111/all.13086. PMC 5462600. PMID 27859351. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462600/. 
  32. ^ a b Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J (February 2011). “Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences”. Nature Communications 2 (2): 180. Bibcode2011NatCo...2..180B. doi:10.1038/ncomms1180. PMC 3040683. PMID 21285958. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040683/. 
  33. ^ a b Oushy S, Hellwinkel JE, Wang M, Nguyen GJ, Gunaydin D, Harland TA, Anchordoquy TJ, Graner MW (January 2018). “Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype”. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 373 (1737): 20160477. doi:10.1098/rstb.2016.0477. PMC 5717433. PMID 29158308. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717433/. 
  34. ^ Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK (January 2010). “Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs”. Nucleic Acids Research 38 (1): 215-24. doi:10.1093/nar/gkp857. PMC 2800221. PMID 19850715. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800221/. 
  35. ^ Gebert LF, MacRae IJ (January 2019). “Regulation of microRNA function in animals”. Nature Reviews. Molecular Cell Biology 20 (1): 21-37. doi:10.1038/s41580-018-0045-7. PMC 6546304. PMID 30108335. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546304/. 
  36. ^ a b Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK (June 2010). “Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes”. Molecular & Cellular Proteomics 9 (6): 1085-99. doi:10.1074/mcp.M900381-MCP200. PMC 2877972. PMID 20124223. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877972/. 
  37. ^ Witwer KW, Théry C (2019). “Extracellular vesicles or exosomes? On primacy, precision, and popularity influencing a choice of nomenclature.”. Journal of Extracellular Vesicles 8 (1): 1648167. doi:10.1080/20013078.2019.1648167. PMC 6711079. PMID 31489144. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711079/. 
  38. ^ a b 再生医療等安全性確保法における再生医療等のリスク分類・法の適用除外範囲の見直しに資する研究報告書” (PDF). 厚生労働省 (2021年8月20日). 2023年2月28日閲覧。
  39. ^ Mignot G, Roux S, Thery C, Ségura E, Zitvogel L (2006). “Prospects for exosomes in immunotherapy of cancer”. Journal of Cellular and Molecular Medicine 10 (2): 376-88. doi:10.1111/j.1582-4934.2006.tb00406.x. PMC 3933128. PMID 16796806. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933128/. 
  40. ^ Bell BM, Kirk ID, Hiltbrunner S, Gabrielsson S, Bultema JJ (January 2016). “Designer exosomes as next-generation cancer immunotherapy”. Nanomedicine 12 (1): 163-9. doi:10.1016/j.nano.2015.09.011. PMID 26500074. 
  41. ^ Pisitkun T, Shen RF, Knepper MA (September 2004). “Identification and proteomic profiling of exosomes in human urine”. Proceedings of the National Academy of Sciences of the United States of America 101 (36): 13368-73. Bibcode2004PNAS..10113368P. doi:10.1073/pnas.0403453101. PMC 516573. PMID 15326289. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC516573/. 
  42. ^ Urinary Exosome Protein Database”. NHLBI (2009年5月12日). 2009年10月1日閲覧。
  43. ^ Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, Widmark A (May 2009). “Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer”. British Journal of Cancer 100 (10): 1603-7. doi:10.1038/sj.bjc.6605058. PMC 2696767. PMID 19401683. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696767/. 
  44. ^ Fat capsules carry markers for deadly prostate cancer”. The Medical News (2009年5月13日). 2009年10月1日閲覧。
  45. ^ Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, Tabi Z, Clayton A (January 2009). “Can urinary exosomes act as treatment response markers in prostate cancer?”. Journal of Translational Medicine 7 (1): 4. doi:10.1186/1479-5876-7-4. PMC 2631476. PMID 19138409. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631476/. 
  46. ^ Webber J, Steadman R, Mason MD, Tabi Z, Clayton A (December 2010). “Cancer exosomes trigger fibroblast to myofibroblast differentiation”. Cancer Research 70 (23): 9621-30. doi:10.1158/0008-5472.CAN-10-1722. PMID 21098712. 
  47. ^ a b Pucci F, Garris C, Lai CP, Newton A, Pfirschke C, Engblom C, Alvarez D, Sprachman M, Evavold C, Magnuson A, von Andrian UH, Glatz K, Breakefield XO, Mempel TR, Weissleder R, Pittet MJ (April 2016). “SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions”. Science 352 (6282): 242-6. Bibcode2016Sci...352..242P. doi:10.1126/science.aaf1328. PMC 4960636. PMID 26989197. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960636/. 
  48. ^ Kobayashi M, Salomon C, Tapia J, Illanes SE, Mitchell MD, Rice GE (January 2014). “Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200”. Journal of Translational Medicine 12: 4. doi:10.1186/1479-5876-12-4. PMC 3896684. PMID 24393345. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896684/. 
  49. ^ Williams C, Royo F, Aizpurua-Olaizola O, Pazos R, Boons GJ, Reichardt NC, Falcon-Perez JM (2018). “Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives”. Journal of Extracellular Vesicles 7 (1): 1442985. doi:10.1080/20013078.2018.1442985. PMC 5844028. PMID 29535851. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844028/. 
  50. ^ Aizpurua-Olaizola O, Toraño JS, Falcon-Perez JM, Williams C, Reichardt N, Boons GJ (2018). “Mass spectrometry for glycan biomarker discovery”. TrAC Trends in Analytical Chemistry 100: 7-14. doi:10.1016/j.trac.2017.12.015. 
  51. ^ Kalra H, Adda CG, Liem M, Ang CS, Mechler A, Simpson RJ, Hulett MD, Mathivanan S (November 2013). “Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma”. Proteomics 13 (22): 3354-64. doi:10.1002/pmic.201300282. PMID 24115447. 
  52. ^ Syn N, Wang L, Sethi G, Thiery JP, Goh BC (July 2016). “Exosome-Mediated Metastasis: From Epithelial-Mesenchymal Transition to Escape from Immunosurveillance”. Trends in Pharmacological Sciences 37 (7): 606-617. doi:10.1016/j.tips.2016.04.006. PMID 27157716. 
  53. ^ Barros ER, Carvajal CA (2017-09-08). “Urinary Exosomes and Their Cargo: Potential Biomarkers for Mineralocorticoid Arterial Hypertension?”. Frontiers in Endocrinology 8: 230. doi:10.3389/fendo.2017.00230. PMC 5599782. PMID 28951728. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599782/. 
  54. ^ a b Tofaris GK (2017). “A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson's Disease”. Journal of Parkinson's Disease 7 (4): 569-576. doi:10.3233/JPD-171176. PMC 5676982. PMID 28922170. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676982/. 
  55. ^ Dhondt B, Rousseau Q, De Wever O, Hendrix A (September 2016). “Function of extracellular vesicle-associated miRNAs in metastasis”. Cell and Tissue Research 365 (3): 621-41. doi:10.1007/s00441-016-2430-x. hdl:1854/LU-7250365. PMID 27289232. 
  56. ^ Prieto D, Sotelo N, Seija N, Sernbo S, Abreu C, Durán R, Gil M, Sicco E, Irigoin V, Oliver C, Landoni AI, Gabus R, Dighiero G, Oppezzo P (August 2017). “S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-κB activity during disease progression”. Blood 130 (6): 777-788. doi:10.1182/blood-2017-02-769851. PMID 28596424. 
  57. ^ Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P, Labori KJ, Kure EH, Grandgenett PM, Hollingsworth MA, de Sousa M, Kaur S, Jain M, Mallya K, Batra SK, Jarnagin WR, Brady MS, Fodstad O, Muller V, Pantel K, Minn AJ, Bissell MJ, Garcia BA, Kang Y, Rajasekhar VK, Ghajar CM, Matei I, Peinado H, Bromberg J, Lyden D (November 2015). “Tumour exosome integrins determine organotropic metastasis”. Nature 527 (7578): 329-35. Bibcode2015Natur.527..329H. doi:10.1038/nature15756. PMC 4788391. PMID 26524530. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788391/. 
  58. ^ Hui WW, Hercik K, Belsare S, Alugubelly N, Clapp B, Rinaldi C, Edelmann MJ (February 2018). “Salmonella enterica Serovar Typhimurium Alters the Extracellular Proteome of Macrophages and Leads to the Production of Proinflammatory Exosomes”. Infection and Immunity 86 (2): e00386-17. doi:10.1128/IAI.00386-17. PMC 5778363. PMID 29158431. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778363/. 
  59. ^ a b c Hessvik NP, Llorente A (January 2018). “Current knowledge on exosome biogenesis and release”. Cellular and Molecular Life Sciences 75 (2): 193-208. doi:10.1007/s00018-017-2595-9. PMC 5756260. PMID 28733901. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756260/. 
  60. ^ Wollert T, Hurley JH (April 2010). “Molecular mechanism of multivesicular body biogenesis by ESCRT complexes”. Nature 464 (7290): 864-9. doi:10.1038/nature08849. PMC 2851844. PMID 20305637. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851844/. 
  61. ^ Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E, Zimmermann P, David G (June 2012). “Syndecan-syntenin-ALIX regulates the biogenesis of exosomes”. Nature Cell Biology 14 (7): 677-85. doi:10.1038/ncb2502. PMID 22660413. 
  62. ^ Möbius W, Ohno-Iwashita Y, van Donselaar EG, Oorschot VM, Shimada Y, Fujimoto T, Heijnen HF, Geuze HJ, Slot JW (January 2002). “Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O”. The Journal of Histochemistry and Cytochemistry 50 (1): 43-55. doi:10.1177/002215540205000105. PMID 11748293. 
  63. ^ Mathieu M, Martin-Jaular L, Lavieu G, Théry C (January 2019). “Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication”. Nature Cell Biology 21 (1): 9-17. doi:10.1038/s41556-018-0250-9. PMID 30602770. 
  64. ^ Villarroya-Beltri C, Gutiérrez-Vázquez C, Sánchez-Cabo F, Pérez-Hernández D, Vázquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M, Sánchez-Madrid F (December 2013). “Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs”. Nature Communications 4 (1): 2980. doi:10.1038/ncomms3980. PMC 3905700. PMID 24356509. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905700/. 
  65. ^ a b Villarroya-Beltri C, Baixauli F, Gutiérrez-Vázquez C, Sánchez-Madrid F, Mittelbrunn M (October 2014). “Sorting it out: regulation of exosome loading”. Seminars in Cancer Biology 28: 3-13. doi:10.1016/j.semcancer.2014.04.009. PMC 4640178. PMID 24769058. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640178/. 
  66. ^ Thind A, Wilson C (2016). “Exosomal miRNAs as cancer biomarkers and therapeutic targets”. Journal of Extracellular Vesicles 5: 31292. doi:10.3402/jev.v5.31292. PMC 4954869. PMID 27440105. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954869/. 
  67. ^ Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM, Simpson RJ (February 2012). “Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes”. Methods 56 (2): 293-304. doi:10.1016/j.ymeth.2012.01.002. PMID 22285593. 
  68. ^ Van Deun J, Mestdagh P, Sormunen R, Cocquyt V, Vermaelen K, Vandesompele J, Bracke M, De Wever O, Hendrix A (2014). “The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling”. Journal of Extracellular Vesicles 3: 24858. doi:10.3402/jev.v3.24858. PMC 4169610. PMID 25317274. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169610/. 
  69. ^ Böing AN, van der Pol E, Grootemaat AE, Coumans FA, Sturk A, Nieuwland R (2014). “Single-step isolation of extracellular vesicles by size-exclusion chromatography”. Journal of Extracellular Vesicles 3: 23430. doi:10.3402/jev.v3.23430. PMC 4159761. PMID 25279113. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159761/. 
  70. ^ Dhondt, Bert; Geeurickx, Edward; Tulkens, Joeri; Van Deun, Jan; Vergauwen, Glenn; Lippens, Lien; Miinalainen, Ilkka; Rappu, Pekka et al. (11 March 2020). “Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine”. Journal of Extracellular Vesicles 9 (1): 1736935. doi:10.1080/20013078.2020.1736935. 
  71. ^ Geeurickx, Edward; Tulkens, Joeri; Dhondt, Bert; Van Deun, Jan; Lippens, Lien; Vergauwen, Glenn; Heyrman, Elisa; De Sutter, Delphine et al. (23 July 2019). “The generation and use of recombinant extracellular vesicles as biological reference material”. Nature Communications 10 (1). doi:10.1038/s41467-019-11182-0. 
  72. ^ van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, Nieuwland R (December 2010). “Optical and non-optical methods for detection and characterization of microparticles and exosomes”. Journal of Thrombosis and Haemostasis 8 (12): 2596-607. doi:10.1111/j.1538-7836.2010.04074.x. PMID 20880256. https://semanticscholar.org/paper/52c6fdee15925b307210de8e1c44fc6126626ff7. 
  73. ^ Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS, Hochberg FH, Breakefield XO, Weissleder R, Lee H (December 2012). “Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy”. Nature Medicine 18 (12): 1835-40. doi:10.1038/nm.2994. PMC 3518564. PMID 23142818. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518564/. 
  74. ^ Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, Lee H (May 2014). “Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor”. Nature Biotechnology 32 (5): 490-5. doi:10.1038/nbt.2886. PMC 4356947. PMID 24752081. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356947/. 
  75. ^ Jeong S, Park J, Pathania D, Castro CM, Weissleder R, Lee H (February 2016). “Integrated Magneto-Electrochemical Sensor for Exosome Analysis”. ACS Nano 10 (2): 1802-9. doi:10.1021/acsnano.5b07584. PMC 4802494. PMID 26808216. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802494/. 
  76. ^ Shao H, Chung J, Lee K, Balaj L, Min C, Carter BS, Hochberg FH, Breakefield XO, Lee H, Weissleder R (May 2015). “Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma”. Nature Communications 6: 6999. Bibcode2015NatCo...6.6999S. doi:10.1038/ncomms7999. PMC 4430127. PMID 25959588. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430127/. 
  77. ^ a b van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG (May 2012). “Single vs. swarm detection of microparticles and exosomes by flow cytometry”. Journal of Thrombosis and Haemostasis 10 (5): 919-30. doi:10.1111/j.1538-7836.2012.04683.x. PMID 22394434. https://semanticscholar.org/paper/783c809559e499ced107e152b2aee99ed2510257. 
  78. ^ Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia Rodriguez P, Bertina RM, Osanto S (February 2010). “Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles”. Journal of Thrombosis and Haemostasis 8 (2): 315-23. doi:10.1111/j.1538-7836.2009.03654.x. PMID 19840362. https://semanticscholar.org/paper/3babfaf8073b600973700f079acf88b32a27bf38. 
  79. ^ Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, Harrison P, Sargent IL (December 2011). “Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis”. Nanomedicine 7 (6): 780-8. doi:10.1016/j.nano.2011.04.003. PMC 3280380. PMID 21601655. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280380/. 
  80. ^ Tatischeff I, Larquet E, Falcón-Pérez JM, Turpin PY, Kruglik SG (2012). “Fast characterisation of cell-derived extracellular vesicles by nanoparticles tracking analysis, cryo-electron microscopy, and Raman tweezers microspectroscopy”. Journal of Extracellular Vesicles 1: 19179. doi:10.3402/jev.v1i0.19179. PMC 3760651. PMID 24009887. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760651/. 
  81. ^ Pathan M, Keerthikumar S, Ang CS, Gangoda L, Quek CY, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim A, Bacic A, Hill AF, Stroud DA, Ryan MT, Agbinya JI, Mariadason JM, Burgess AW, Mathivanan S (August 2015). “FunRich: An open access standalone functional enrichment and interaction network analysis tool”. Proteomics 15 (15): 2597-601. doi:10.1002/pmic.201400515. PMID 25921073. 
  82. ^ Gaur P, Chaturvedi A (2016). “Trypanosoma cruzi: a step closer to early diagnosis of neglected Chagas disease”. PeerJ 4: e2693. doi:10.7717/peerj.2693. PMC 5126619. PMID 27904804. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126619/. 
  83. ^ Gaur P, Chaturvedi A (2016-11-24). “Trypanosoma cruzi: a step closer to early diagnosis of neglected Chagas disease”. PeerJ 4: e2693. doi:10.7717/peerj.2693. PMC 5126619. PMID 27904804. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126619/. 
  84. ^ Han C, Sun X, Liu L, Jiang H, Shen Y, Xu X, Li J, Zhang G, Huang J, Lin Z, Xiong N, Wang T (2016). “Exosomes and Their Therapeutic Potentials of Stem Cells”. Stem Cells International 2016: 7653489. doi:10.1155/2016/7653489. PMC 4684885. PMID 26770213. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684885/. 
  85. ^ Yeo, R. W. Y., & Lim, S. K. (2016). Exosomes and their Therapeutic Applications. In ADVANCES IN PHARMACEUTICAL CELL THERAPY: Principles of Cell-Based Biopharmaceuticals (pp. 477-501). ISBN 978-981-4616-80-5
  86. ^ Di Rocco G, Baldari S, Toietta G (2016). “In Vivo Tracking and Biodistribution Analysis”. Stem Cells International 2016: 5029619. doi:10.1155/2016/5029619. PMC 5141304. PMID 27994623. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141304/. 
  87. ^ Elahi FM, Farwell DG, Nolta JA, Anderson JD (August 2019). “Preclinical translation of exosomes derived from mesenchymal stem/stromal cells”. Stem Cells 0. doi:10.1002/stem.3061. PMID 31381842. 
  88. ^ Basu J, Ludlow JW (2016). “Exosomes for repair, regeneration and rejuvenation”. Expert Opinion on Biological Therapy 16 (4): 489-506. doi:10.1517/14712598.2016.1131976. PMID 26817494. 
  89. ^ MSC-derived Exosomes Promote Bone Fracture Repair”. Stem Cells Portal (2017年1月2日). 2020年5月5日閲覧。
  90. ^ Silva AM, Teixeira JH, Almeida MI, Gonçalves RM, Barbosa MA, Santos SG (February 2017). “Extracellular Vesicles: Immunomodulatory messengers in the context of tissue repair/regeneration”. European Journal of Pharmaceutical Sciences 98: 86-95. doi:10.1016/j.ejps.2016.09.017. PMID 27644894. 
  91. ^ Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E (July 2015). “Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro”. Stem Cells and Development 24 (14): 1635-47. doi:10.1089/scd.2014.0316. PMC 4499790. PMID 25867197. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499790/. 
  92. ^ Geiger A, Walker A, Nissen E (November 2015). “Human fibrocyte-derived exosomes accelerate wound healing in genetically diabetic mice”. Biochemical and Biophysical Research Communications 467 (2): 303-9. doi:10.1016/j.bbrc.2015.09.166. PMID 26454169. 
  93. ^ Sjöqvist S, Ishikawa T, Shimura D, Kasai Y, Imafuku A, Bou-Ghannam S, Iwata T, Kanai N (20 January 2019). “Exosomes derived from clinical-grade oral mucosal epithelial cell sheets promote wound healing”. Journal of Extracellular Vesicles 8 (1): 1565264. doi:10.1080/20013078.2019.1565264. PMC 6346716. PMID 30719240. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346716/. 
  94. ^ Wahlgren J, Statello L, Skogberg G, Telemo E, Valadi H (2016). “Delivery of Small Interfering RNAs to Cells via Exosomes”. SiRNA Delivery Methods. Methods in Molecular Biology. 1364. pp. 105-25. doi:10.1007/978-1-4939-3112-5_10. ISBN 978-1-4939-3111-8. PMID 26472446 
  95. ^ Kumar L, Verma S, Vaidya B, Gupta V (2015). “Exosomes: Natural Carriers for siRNA Delivery”. Current Pharmaceutical Design 21 (31): 4556-65. doi:10.2174/138161282131151013190112. PMID 26486142. 
  96. ^ Batrakova EV, Kim MS (December 2015). “Using exosomes, naturally-equipped nanocarriers, for drug delivery”. Journal of Controlled Release 219: 396-405. doi:10.1016/j.jconrel.2015.07.030. PMC 4656109. PMID 26241750. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656109/. 
  97. ^ Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O, Hingtgen SD, Kabanov AV, Batrakova EV (April 2016). “Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells”. Nanomedicine 12 (3): 655-664. doi:10.1016/j.nano.2015.10.012. PMC 4809755. PMID 26586551. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809755/. 





英和和英テキスト翻訳>> Weblio翻訳
英語⇒日本語日本語⇒英語
  
  •  エクソソーム (小胞)のページへのリンク

辞書ショートカット

すべての辞書の索引

「エクソソーム (小胞)」の関連用語

エクソソーム (小胞)のお隣キーワード
検索ランキング

   

英語⇒日本語
日本語⇒英語
   



エクソソーム (小胞)のページの著作権
Weblio 辞書 情報提供元は 参加元一覧 にて確認できます。

   
ウィキペディアウィキペディア
All text is available under the terms of the GNU Free Documentation License.
この記事は、ウィキペディアのエクソソーム (小胞) (改訂履歴)の記事を複製、再配布したものにあたり、GNU Free Documentation Licenseというライセンスの下で提供されています。 Weblio辞書に掲載されているウィキペディアの記事も、全てGNU Free Documentation Licenseの元に提供されております。

©2024 GRAS Group, Inc.RSS